The Gut-Kidney Axis in IgAN: Can Novel Therapies Change the Disease Paradigm?

Guideline-orientated management of immunoglobulin A nephropathy (IgAN) includes enrolling patients who remain proteinuric despite optimized standard of care in clinical trials.

Credit available for this activity expires: 3/22/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989932?ecd=bdc_podcast_libsyn_mscpedu